HKSE - Delayed Quote HKD

CANBRIDGE-B (1228.HK)

Compare
0.152 -0.003 (-1.94%)
At close: 3:58:53 PM GMT+8
Currency in CNY All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
102,871.000
102,871.000
78,972.000
31,161.000
12,032.000
Cost of Revenue
38,707.000
38,707.000
30,078.000
12,385.000
5,154.000
Gross Profit
64,164.000
64,164.000
48,894.000
18,776.000
6,878.000
Operating Expense
429,278.000
429,278.000
498,409.000
673,518.000
237,971.000
Operating Income
-365,114.000
-365,114.000
-449,515.000
-654,742.000
-231,093.000
Net Non Operating Interest Income Expense
2,029.000
2,029.000
-2,970.000
-472.000
-2,909.000
Pretax Income
-378,837.000
-378,837.000
-483,475.000
-1,077,006.000
-846,043.000
Net Income Common Stockholders
-378,837.000
-378,837.000
-483,475.000
-1,077,006.000
-846,043.000
Diluted NI Available to Com Stockholders
-378,837.000
-378,837.000
-483,475.000
-1,077,006.000
-846,043.000
Basic EPS
-0.89
--
-1.14
-11.43
-1.99
Diluted EPS
-0.89
--
-1.14
-11.43
-1.99
Basic Average Shares
424,378.752
--
424,210.824
94,241.487
424,191.920
Diluted Average Shares
424,378.752
--
424,210.824
94,241.487
424,191.920
Total Expenses
467,985.000
467,985.000
528,487.000
685,903.000
243,125.000
Net Income from Continuing & Discontinued Operation
-378,837.000
-378,837.000
-483,475.000
-1,077,006.000
-846,043.000
Normalized Income
-379,075.000
-379,075.000
-483,910.000
-1,121,187.000
-825,297.000
Interest Income
10,977.000
10,977.000
3,893.000
2,607.000
964.000
Interest Expense
8,948.000
8,948.000
6,863.000
3,079.000
3,794.000
Net Interest Income
2,029.000
2,029.000
-2,970.000
-472.000
-2,909.000
EBIT
-369,889.000
-369,889.000
-476,612.000
-1,073,927.000
-842,249.000
EBITDA
-341,429.000
-341,429.000
-454,634.000
-1,058,221.000
-824,410.000
Reconciled Cost of Revenue
38,707.000
38,707.000
30,078.000
12,385.000
5,154.000
Reconciled Depreciation
28,460.000
28,460.000
21,978.000
15,706.000
17,839.000
Net Income from Continuing Operation Net Minority Interest
-378,837.000
-378,837.000
-483,475.000
-1,077,006.000
-846,043.000
Total Unusual Items Excluding Goodwill
238.000
238.000
435.000
44,181.000
-20,746.000
Total Unusual Items
238.000
238.000
435.000
44,181.000
-20,746.000
Normalized EBITDA
-341,667.000
-341,667.000
-455,069.000
-1,102,402.000
-803,664.000
12/31/2020 - 12/10/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

000710.SZ Berry Genomics Co.,Ltd
11.02
-0.36%
 
0ITA.BE Satellos Bioscience Inc
0.6700
+4.69%
 
6628.HK Transcenta Holding Limited
0.610
0.00%
 
2105.HK Laekna, Inc.
10.840
-8.75%
 
2616.HK CStone Pharmaceuticals
2.710
+3.04%
 
MSCLF Satellos Bioscience Inc.
0.7200
0.00%
 
PEPG PepGen Inc.
3.3761
-27.86%
 
TRDA Entrada Therapeutics, Inc.
17.72
+0.34%
 
ARGX.BR argenx SE
603.80
+3.96%
 
XLO Xilio Therapeutics, Inc.
0.9300
-3.74%